New Survey Showed GI Health and Anti-Aging Benefits of Morinaga's Probiotics Milk with BB536
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), Japanese leading dairy product company, today unveiled the results of a nationwide survey jointly conducted with Tokyo Healthcare University in Japan on the health status of over 20,000 middle-aged to elderly men and women for the purpose of investigating the relationship between regular consumption of calcium-fortified milk containing Bifidobacterium longum BB536 and health status.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151119005020/en/
The results reveal that subjects regularly consuming the probiotic milk were less likely to experience fractures and several diseases, and showed improvement in forgetfulness, quality of life in daily living, which supports the benefits of B. longum BB536 for anti-aging.
“The results obtained from this survey linked the continuous consumption of the probiotic milk supplemented with B. longum BB536 for reducing some disease risks, such as colon cancer, and in helping to prevent certain aging-related challenges of middle-aged to elderly people, in such areas as forgetfulness for example,” stated Dr. Taeko Shimoda, professor of Tenshi College, professor emeritus of Tokyo Healthcare University.
“Although other components in the milk, such as calcium, might have also contributed to the outcomes of the present survey, B. longum BB536 is believed to possess an important function from a point of view of improving intestinal health and the relationship with the gut-brain axis.”
The Survey Shows the Potential of Probiotic Milk Consumption for Anti-Aging
Questionnaires were distributed to middle-aged to elderly men and women aged in their 50s to 80s with or without experience of consuming “calcium fortified milk containing BB536,” from December 2013 to March 2014. A total of 92,110 questionnaires were distributed and 23,188 effective answers were received. Data analysis was performed by comparison between subjects with experience of the probiotic milk consumption for ≥ 3 years and for ≥4 times per week and subjects without experience of consumption of this probiotic milk.
Compared with the non-intake group, the probiotic milk-consuming group (intake group) showed the following;
- The proportions of subjects who had (a tendency to) constipation were lower in both men and women.
- The proportions of subjects who experienced forgetfulness (men and women), fatigue (women) and low back pain (women) in daily life were lower.
- The proportions of subjects who experienced colon polyp (men), kidney disease (women), liver disease (men) and gallstones (men) were lower.
- For women who had consumed the milk for over 10 years, fewer subjects experienced bone fractures in the past 5 years.
Risk for experiencing forgetfulness in daily life (Fig.1)
The result showed that there was a significant reduction of risk for forgetfulness by 19% (P = 0.03) and 14% (P = 0.002) for men and women, respectively, in the intake group compared to non-intake group.
B. longum BB536 (ATCC BAA-999) has been reported to be effective in normalizing anxiety-like behavior and hippocampal brain derived neurotrophic factor in mice with infectious colitis (Bercik et al., 2011). The present survey supported the possible effect of consumption of BB536 supplemented milk for improving brain health via the gut-brain axis.
Risk for developing a colon polyp
There was a significant reduction of risk for history development of a colon polyp by 26% (P = 0.003) for men in the intake group compared to non-intake group. B. longum BB536 has shown its effect in suppressing the development of carcinogenesis induced by carcinogen in male and female rats (Reddy and Rivenson,1993). In addition, intake of yogurt containing B. longum BB536 lowered the cell number of enterotoxigenic Bacteroides fragilis (ETBF), a bacteria which has been suggested to be associated with diarrheal disease, inflammatory bowel disease and colorectal cancer (Odamaki et al., 2012). The present survey suggests the possible effect of consumption of the probiotic milk supplemented with B. longum BB536 in lowering the risk of colon cancer.
Risk of experiencing bone fractures in the past 5 years
The proportion of history of bone fractures in the past 5 years was significantly lower in the intake group compared to non-intake group for women, with a significant reduction of risk for experiencing bone fractures by 16% (P = 0.04). The proportion of history of bone fractures in men was lower than that in women, and there was no significant difference between the intake and non-intake groups.
Igarashi et al. (1994) reported that a simultaneous administration of B. longum BB536 and milk calcium was more effective in improving the bone strength as compared to administration of calcium alone in rats. The present survey suggested the potential for B. longum BB536 in lowering the risk of bone fractures.
About BB536 and Morinaga
Bifidobacterium longum BB536 was isolated from human intestine and is one of the most thoroughly researched probiotic strains in the world. Morinaga has conducted research and development on BB536 for over 40 years, and achieved U.S. FDA-notified GRAS in 2009. Supported by over 110 published studies, BB536’s beneficial effects have been confirmed in such clinical areas as intestinal health, immunity, infection, and allergy.
Morinaga Milk Industry Co., Ltd. is the second largest dairy product company in Japan, founded in 1917 and employing 3,080 people. Morinaga has exhibited excellence in the field of technology and has offered not only dairy products but also other beneficial functional ingredients to the world for years. For more information, visit us at http://www.morinagamilk.co.jp/english/.
P. Bercik et al., The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut–brain communication; Neurogastroenterol Motil. 23(12):1132-9 (2011)
S. Reddy and Abraham Rivenson, Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f] quinoline, a food mutagen; Cancer Research 53 : 3914-3918 (1993)
T.Odamaki et al., Effect of the oral intake of yogurt containing Bifidobacterium longum BB536 on the cell numbers of enterotoxigenic Bacteroides fragilis in microbiota; Anaerobe. 18(1)14-18 (2012)
M. Igarashi et al., Effect of Bifidobacterium longum and lactulose on the strength of bone in ovariectomized osteoporosis model rats; Bifidus 7 : 139-147 (1994)
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
H.I.G. Capital Announces the Sale of KidsFoundation19.7.2018 19:50 | Pressemelding
H.I.G. Capital (“H.I.G.”), a leading global private equity investment firm with more than €21 billion of equity capital under management, announced today that one of its affiliates has entered a definitive agreement to sell the KidsFoundation Group (“KidsFoundation”), the Dutch market leader in childcare services, to Onex Corporation (“Onex”)(TSX:ONEX). Terms were not disclosed. Headquartered in Almere, the Netherlands, KidsFoundation provides high-quality childcare to nearly 30,000 children between the ages of six weeks and 12 years. H.I.G. created KidsFoundation in 2014 through the acquisition of assets from the estate of Estro Group. During H.I.G.’s ownership, the company has developed strongly with significant capital invested by H.I.G. to create a high-quality childcare offering. H.I.G. worked with KidsFoundation management to optimise the footprint of the company by exiting loss-making locations, introduce new IT systems to drive operational improvement and develop an internal M&
SIG Combibloc Group Holdings S.à r.l.: 2018 Second Quarter Results19.7.2018 16:01 | Pressemelding
We are pleased to announce our quarterly conference call to discuss the results of SIG Combibloc Group Holdings S.à r.l. for the second quarter ended June 30, 2018. Date: Monday, July 23, 2018 Time: 15.00 CEST / 14.00 BST / 9.00 EDT The call information will be distributed on our secure site. If you would like access to our call, please contact email@example.com . Regards, SIG Combibloc Group Holdings S.à r.l. View source version on businesswire.com: https://www.businesswire.com/news/home/20180719005634/en/ Contact information SIG Combibloc Group Holdings S.à r.l. Jennifer Gough firstname.lastname@example.org
NEORIS Announces Creation of Innovation Labs Worldwide to Create a Smarter Future19.7.2018 15:32 | Pressemelding
NEORIS, a global digital consulting services company, announced today it is consolidating the most innovative solutions it has developed in different geographies and allocating unprecedented resources to deploy a network of Innovation Labs worldwide. The main objective is to lay the foundation for the continuous development of disruptive solutions for its four core industries: Manufacturing, Financial Services, Healthcare and Telecommunications. Due to its disruptive nature, NEORIS decided that its first Innovation Lab should be housed in the Monterrey Digital Hub, which today is the first-of-its-kind as it is a space where entrepreneurs, companies, universities and investors converge to foster an ecosystem for Digital Transformation. The lab inaugurated in Monterrey, Mexico is the first of a series of Innovation Labs that will open in the different countries that NEORIS operates, and is a space where customers can experience emerging technologies through real-life scenarios. One such
CORRECTING and REPLACING Albar Capital Deploys FlexNOW19.7.2018 15:29 | Pressemelding
Subhead of release should read: Out-of-the-Box Multi-Asset Execution Management System (instead of Easy-to-Install Multi-Asset Execution Management System). The corrected release reads: ALBAR CAPITAL DEPLOYS FLEXNOW Out-of-the-Box Multi-Asset Execution Management System FlexTrade (@FlexTrade) today announced that Albar Capital Ltd., a new hedge fund led by Javier Velazquez (formerly of Millennium Capital Partners LLP), is now trading equities and futures using FlexNOW, FlexTrade’s new execution management system. “The FlexNOW team was instrumental in solving several of our problems,” said Jason Ruder, Trader at Albar Capital. “Not only are they helping us with our compliance requirements, they are also responsive to requests that improve my workflow.” According to Rhyd Lewis, FlexNOW Product Manager, FlexNOW’s quick onboarding and easy installation process was critical for Albar Capital’s launch on 2 July. “We had no problem integrating FlexNOW with Albar’s portfolio and risk managemen
Full Core of Westinghouse Fuel Achieved at South-Ukraine Nuclear Power Plant Unit 319.7.2018 13:25 | Pressemelding
Westinghouse Electric Company announced today that Ukraine’s State Enterprise National Nuclear Energy Generation Company (SE NNEGC) Energoatom’s South-Ukraine NPP Unit 3 near Yuzhnoukrainsk in Mykolaiv province was loaded with a full core of Westinghouse VVER-1000 fuel. This is the first unit in Ukraine to operate with Westinghouse VVER-1000 fuel assemblies as the sole fuel source. “Westinghouse began supplying fuel to Ukraine in 2005, when the first lead test assemblies were delivered to South-Ukraine Unit 3,” said Aziz Dag, vice president and managing director, Northern Europe. “We are proud to continue supporting Ukraine with their energy diversification by supplying a full core of Westinghouse VVER-1000 fuel to our customer, Energoatom.” Westinghouse currently supplies fuel to six of Ukraine’s 15 nuclear power reactors. Beginning in 2021, the number of reactors with Westinghouse fuel will increase to seven. “Westinghouse has made significant investments over the last several years
Seoul Semiconductor Delivers Its Innovative LED "SunLike" to U.S. Lighting Market19.7.2018 13:00 | Pressemelding
Seoul Semiconductor Co., Ltd. (KOSDAQ:046890), a market leader in LED (light emitting diode) design and manufacturing, announced that its innovative LED “SunLike” is applied to brand new lightings to be launched by three lighting premium brands in U.S., Pure Edge Lighting, LEDRAbrands, Inc. and Elite Lighting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180719005377/en/ The product of LEDRAbrands, Inc., NU4RA-SUN, which applied SunLike of Seoul Semiconductor (Photo: Business Wire) Seoul Semiconductor supplies SunLike to pendant lighting for Pure Edge, a U.S. lighting solution company. It is applied to high-end lighting for museums and art galleries that require the highest color quality. The leading lighting design companies, LEDRAbrands, Inc. and Elite Lighting, apply SunLike to downlights and spotlights respectively. “We have selected Seoul Semiconductor’s innovative LED SunLike for our human centric lighting and believ